Stock Events

Biomarin Pharmaceutical (BMRN) Q2 2018 Earnings

25AprConfirmed
Q3 2017
Q4 2017
Q1 2018
Q2 2018
-0.4
-0.29
-0.18
-0.07

Details

Expected EPS
-0.18
Actual EPS
-0.25
Surprise EPS
-0.07
Surprise Percent
+38.89%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.25 per share for Q2 2018.

0 Comments

Share your thoughts